3 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 3 |
Follow ALL: new trials by email Literature Review of ALL trials Research Report on ALL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy Infusion of CD34 selected hematopoietic stem cells - AML, ALL | Phase 1 | Recruiting | University of Alabama at Birmingham | 50 | 2025-04-22 | 2026-04-13 |
| Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies Tagraxofusp, Fludarabine, Cytarabine - Hematologic Malignancy, AML | Phase 1 | Recruiting | Therapeutic Advances in Childhood Leukemia Consortium | 54 | 2022-11-11 | 2024-12-06 |
| Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia Ruxolitinib, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, ALL, Childhood | Phase 1 | Recruiting | University of Chicago | 15 | 2019-05-28 | 2026-06-29 |
Hematologic Neoplasms (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Hodgkin Disease (1) · Leukemia, Biphenotypic, Acute (1) · Lymphoma, B-Cell (1) · Lymphoma, T-Cell (1) · Myelodysplastic Syndromes (1) · Primary Myelofibrosis (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Neoplasms (3) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Bone Marrow Diseases (1) · Histiocytic Disorders, Malignant (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1)
Cytarabine (2) · Dexamethasone (2) · Methotrexate (2) · Vincristine (2) · Administration, Intravenous (1) · Azacitidine (1) · Calcium Dobesilate (1) · Cyclophosphamide (1) · Doxorubicin (1) · Hydrocortisone (1) · Mercaptopurine (1) · Rituximab (1) · Thioguanine (1) · fludarabine (1) · pegaspargase (1)
Therapeutic Advances in Childhood Leukemia Consortium (1) · University of Alabama at Birmingham (1) · University of Chicago (1)
United States (3) · Australia (1)
Adam Lamble, MD (1) · Wendy Stock, MD (1)